Cardio Diagnostics Financials

CDIOW Stock  USD 0.1  0.01  7.62%   
Based on the key indicators related to Cardio Diagnostics' liquidity, profitability, solvency, and operating efficiency, Cardio Diagnostics Holdings is not in a good financial situation at this time. It has a very high odds of going through financial crisis in January. Key indicators impacting Cardio Diagnostics' financial strength include:
Operating Margin
(162.96)
Return On Equity
(2.93)
  
Understanding current and past Cardio Diagnostics Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Cardio Diagnostics' financial statements are interrelated, with each one affecting the others. For example, an increase in Cardio Diagnostics' assets may result in an increase in income on the income statement.
Please note, the imprecision that can be found in Cardio Diagnostics' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Cardio Diagnostics Holdings. Check Cardio Diagnostics' Beneish M Score to see the likelihood of Cardio Diagnostics' management manipulating its earnings.

Cardio Diagnostics Stock Summary

Cardio Diagnostics competes with Cardio Diagnostics. Cardio Diagnostics Inc. develops and manufactures a genetic and epigenetic based test for prevention and detection of cardiovascular disease. Cardio Diagnostics Inc. was founded in 2017 and is based in Chicago, Illinois. Cardio Diagnostics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange.
Specialization
Health Care, Pharmaceuticals, Biotechnology & Life Sciences
InstrumentUSA Stock View All
ExchangeNASDAQ Exchange
CUSIP56168P120 14159C111
LocationIllinois; U.S.A
Business Address311 West Superior
SectorBiotechnology
IndustryHealth Care
BenchmarkDow Jones Industrial
Websitecardiodiagnosticsinc.com
Phone302 281 2147
CurrencyUSD - US Dollar

Cardio Diagnostics Key Financial Ratios

Cardio Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Cardio Diagnostics's current stock value. Our valuation model uses many indicators to compare Cardio Diagnostics value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Cardio Diagnostics competition to find correlations between indicators driving Cardio Diagnostics's intrinsic value. More Info.
Cardio Diagnostics Holdings is rated fourth in return on equity category among its peers. It also is rated fourth in return on asset category among its peers . Comparative valuation analysis is a catch-all technique that is used if you cannot value Cardio Diagnostics by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.

Cardio Diagnostics Systematic Risk

Cardio Diagnostics' systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Cardio Diagnostics volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
Execute Function
The function did not generate any output. Please change time horizon or modify your input parameters. The output start index for this execution was one with a total number of output elements of sixty. The Beta measures systematic risk based on how returns on Cardio Diagnostics correlated with the market. If Beta is less than 0 Cardio Diagnostics generally moves in the opposite direction as compared to the market. If Cardio Diagnostics Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Cardio Diagnostics is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Cardio Diagnostics is generally in the same direction as the market. If Beta > 1 Cardio Diagnostics moves generally in the same direction as, but more than the movement of the benchmark.

Steps to analyze company Financials for Investing

There are several different ways that investors can use financial statements to try and predict whether a stock price will go up or down. Unfortunately, there is no surefire formula, but there are some general guidelines you should consider when looking at the numbers. First, realize what kind of company it is so you know if its revenues are more likely to grow or shrink over time. For example, a software company's revenue is expected to increase yearly due to new products and services that its customers will want to buy. At the same time, a car manufacturer might not be able to sell as many cars when the economy slows down, so it would have less net income during those times. Second, pay attention to its debt-to-equity ratio because this number will tell you how much risk it has. If a company such as Cardio Diagnostics is not taking on any additional risks, its debt-to-equity should be less than one. As a general rule of thumb, if the market value or book value (which can be found in the footnotes) of assets exceeds the company's liabilities, then it is probably in good shape. Finally, use other financial statements to determine if a stock price will go up or down because investors are always looking for growth opportunities when they buy new stocks. For example, if you see that the net revenue of Cardio has grown by more than 25% over the last five years, then there is a good chance that it will continue growing by at least 20% or more each year. On the other hand, if you see that net revenue has only increased by about 15%, which is barely above inflation levels, then chances are it will not grow much faster than this over time, and investors may shy away from buying it.
In summary, you can determine if Cardio Diagnostics' financials are consistent with your investment objective using the following steps:
  • Review Cardio Diagnostics' balance sheet accounts, such as liabilities and equity, to understand its overall financial position.
  • Analyze the income statement and examine the company's revenue, expenses, and profits over time to determine its financial performance.
  • Study the cash flow inflows and outflows to understand Cardio Diagnostics' liquidity and solvency.
  • Look at the growth rates in revenue, earnings, and cash flow over time to determine its potential for future growth.
  • Compare Cardio Diagnostics' financials to those of its peers to see how it stacks up and identify any potential red flags.
  • Use valuation ratios to evaluate the company's financials using commonly used ratios such as the price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and enterprise value-to-earnings before interest, taxes, depreciation, and amortization (EV/EBITDA) ratio to determine if Cardio Diagnostics' stock is overvalued or undervalued.
Remember, these are just guidelines and should not be the only basis for investment decisions. It is always important to analyze the leading stock market indicators., conduct additional research and seek professional advice if needed.

Cardio Diagnostics Thematic Clasifications

Cardio Diagnostics Holdings is part of Pharmaceutical Products investing theme. If you are a theme-oriented, socially responsible, and at the same time, a result-driven investor, you can align your investing habits with your values without jeopardizing your expectations about returns. You can easily create an optimal portfolio of stocks, ETFs, funds, or cryptocurrencies based on a specific theme of your liking. USA Equities from Pharmaceutical Products industry as classified by Fama & French. Fama and French investing themes focus on testing asset pricing under different economic assumptions
Pharmaceutical ProductsView
This theme covers USA Equities from Pharmaceutical Products industry as classified by Fama & French. Fama and French investing themes focus on testing asset pricing under different economic assumptions. Get More Thematic Ideas

Cardio Diagnostics December 30, 2024 Opportunity Range

Along with financial statement analysis, the daily predictive indicators of Cardio Diagnostics help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Cardio Diagnostics Holdings. We use our internally-developed statistical techniques to arrive at the intrinsic value of Cardio Diagnostics Holdings based on widely used predictive technical indicators. In general, we focus on analyzing Cardio Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Cardio Diagnostics's daily price indicators and compare them against related drivers.

Additional Tools for Cardio Stock Analysis

When running Cardio Diagnostics' price analysis, check to measure Cardio Diagnostics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cardio Diagnostics is operating at the current time. Most of Cardio Diagnostics' value examination focuses on studying past and present price action to predict the probability of Cardio Diagnostics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cardio Diagnostics' price. Additionally, you may evaluate how the addition of Cardio Diagnostics to your portfolios can decrease your overall portfolio volatility.